Document Detail


Transient sputum eosinophilia may occur over time in non-eosinophilic asthma and this is not prevented by salmeterol.
MedLine Citation:
PMID:  22882543     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
SUMMARY AT A GLANCE: In 60% of patients with non-eosinophilic asthma who received salmeterol monotherapy, low sputum eosinophils persisted over six months. However, transient sputum eosinophilia was observed over time in 40% of patients. This was not associated with clinical deterioration, probably due to suppression of symptoms by salmeterol. ABSTRACT: Background and objective:  Symptomatic, steroid-naive asthmatic patients may have low sputum eosinophil numbers. The study aim was to determine whether low sputum eosinophil numbers persisted over time, during treatment with salmeterol monotherapy. Methods:  Forty steroid-naive, symptomatic asthmatic patients, with sputum eosinophils <3%, were randomized to receive open-label salmeterol (50 µg twice a day, n = 30) or fluticasone (125 µg twice a day, n = 10), and were then assessed at 1, 3 and 6 months. All patients underwent spirometry, a methacholine challenge test and sputum induction at each visit. Symptom scores and peak expiratory flow were recorded throughout the study. Patients were permitted to withdraw from the study at any time, if they experienced exacerbations or deterioration of symptoms. Results:  The average sputum eosinophil percentage remained normal (≤1.9%) in both groups over the study period. The eosinophil percentages were ≤1.9% in 65 of the 80 samples obtained from salmeterol-treated patients throughout the study period. Eight patients had an asthma exacerbation or deterioration, during which one developed sputum eosinophilia. Twelve patients, 11 of whom were randomized to salmeterol and one to fluticasone, developed transient sputum eosinophilia at least once during the study. This was not associated with asthma exacerbation (except for one patient). Sputum neutrophil percentage did not change in either group. Conclusions:  Low sputum eosinophil numbers persisted over six months in a majority of patients with non-eosinophilic asthma who received salmeterol monotherapy. However, transient sputum eosinophilia occurred in 40% indicating that non-eosinophilic asthma may not be a stable phenotype. © 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.
Authors:
Elena Bacci; Manuela Latorre; Silvana Cianchetti; Marialaura Bartoli; Francesco Costa; Antonella Di Franco; Laura Malagrinò; Federica Novelli; Barbara Vagaggini; Federico L Dente; Pierluigi Paggiaro
Related Documents :
22396783 - Interactive rhythmic auditory stimulation reinstates natural 1/f timing in gait of park...
22581063 - Morning blood pressure is useful for detection of left ventricular hypertrophy in hemod...
19779763 - Usefulness and limitations of quantiferon-tb gold in japanese rheumatoid arthritis pati...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-10
Journal Detail:
Title:  Respirology (Carlton, Vic.)     Volume:  -     ISSN:  1440-1843     ISO Abbreviation:  Respirology     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9616368     Medline TA:  Respirology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.
Affiliation:
CardioThoracic and Vascular Department, Pneumology Section, University of Pisa, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intermittent Hydrostatic Pressure Enhances Growth Factor-Induced Chondroinduction of Human Adipose-D...
Next Document:  Killer whale ecotypes: is there a global model?